SEC 13F Intelligence

Boxer Capital, LLC / ICPTUSD

Boxer Capital, LLC’s Intercept Pharmaceuticals In Position

Does Boxer Capital, LLC own Intercept Pharmaceuticals In (ICPTUSD)? Not currently — the last reported position was 1.18M shares worth $49M in Q3 2020; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$49M
Q3 2020
Shares
1.18M
% of Portfolio
+1.68%
Quarters Held
3
position exited

Position History ICPTUSD

Reported value by quarter
Q4 ’18: $60MQ4 ’18Q2 ’20: $6MQ2 ’20Q3 ’20: $49MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20201.18M$49M+1.68%
Q2 2020126.0K$6M+0.27%
Q4 2018600.0K$60M+7.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ICPTUSD.